Recent advances in radiotracers targeting novel cancer-specific biomarkers in China: a brief overview
J Zhang, F Kang, X Wang, X Chen, X Yang… - Journal of Nuclear …, 2024 - Soc Nuclear Med
Radiopharmaceuticals play a critical role in nuclear medicine, providing novel tools for
specifically delivering radioisotopes for the diagnosis and treatment of cancers. As the …
specifically delivering radioisotopes for the diagnosis and treatment of cancers. As the …
Small molecule–and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
J Paulus, N Sewald - Journal of Peptide Science, 2024 - Wiley Online Library
Targeted cancer treatment should avoid side effects and damage to healthy cells commonly
encountered during traditional chemotherapy. By combining small molecule or peptidic …
encountered during traditional chemotherapy. By combining small molecule or peptidic …
Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer
L Chen, H Fu, H He, K Lou, Q Li, J Ye… - Molecular …, 2023 - ACS Publications
Integrin α6 has been considered a promising biomarker, is overexpressed in many tumors,
and plays a vital role in tumor formation, recurrence, and metastasis. In this study, we …
and plays a vital role in tumor formation, recurrence, and metastasis. In this study, we …
Molecular Imaging for Lung Cancer: Exploring Small Molecules, Peptides, and Beyond in Radiolabeled Diagnostics
It is evident that radiolabeled drug delivery systems hold great promise in the field of lung
cancer management. The combination of therapeutic agents with radiotracers not only …
cancer management. The combination of therapeutic agents with radiotracers not only …
Radionuclide-based theranostics—a promising strategy for lung cancer
Purpose This review aims to provide a comprehensive overview of the latest literature on
personalized lung cancer management using different ligands and radionuclide-based …
personalized lung cancer management using different ligands and radionuclide-based …